ALPHA1BETA1 ANTAGONISTS FOR TREATMENT OF ATHEROSCLEROSIS

Details for Australian Patent Application No. 2003215298 (hide)

Owner BIOGEN, INC.

Inventors DE FOUGEROLLES, Antonin, R.; KOTELIANSKI, Victor

Pub. Number AU-A-2003215298

PCT Number PCT/US03/04927

PCT Pub. Number WO2003/068262

Priority 60/357,249 14.02.02 US

Filing date 14 February 2003

Wipo publication date 4 September 2003

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/357,249 14.02.02 US

2 October 2003 Application Open to Public Inspection

  Published as AU-A-2003215298

28 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215299-PATIENT TEMPERATURE CONTROL SYSTEM

2003215297-ENHANCING NEUROTROPHIN-INDUCED NEUROGENESIS BY ENDOGENOUS NEURAL PROGENITOR CELLS BY CONCURRENT OVEREXPRESSION OF BRAIN DERIVED NEUROTROPHIC FACTOR AND AN INHIBITOR OF A PRO-GLIOGENIC BONE MORPHOGENETIC PROTEIN